Cargando…
Screening for Preterm Birth: Potential for a Metabolomics Biomarker Panel
The aim of this preliminary study was to investigate the potential of maternal serum to provide metabolomic biomarker candidates for the prediction of spontaneous preterm birth (SPTB) in asymptomatic pregnant women at 15 and/or 20 weeks’ gestation. Metabolomics LC-MS datasets from serum samples at 1...
Autores principales: | Considine, Elizabeth C., Khashan, Ali S., Kenny, Louise C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572582/ https://www.ncbi.nlm.nih.gov/pubmed/31067710 http://dx.doi.org/10.3390/metabo9050090 |
Ejemplares similares
-
Preterm birth and reduced birthweight in first and second teenage pregnancies: a register-based cohort study
por: Khashan, Ali S, et al.
Publicado: (2010) -
Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth: Preterm SAMBA
por: Cecatti, Jose G., et al.
Publicado: (2016) -
Risk Factors and Birth Outcomes of Anaemia in Early Pregnancy in a Nulliparous Cohort
por: Masukume, Gwinyai, et al.
Publicado: (2015) -
The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth
por: Elshenawy, Summer, et al.
Publicado: (2020) -
Trace biomarkers associated with spontaneous preterm birth from the maternal serum metabolome of asymptomatic nulliparous women – parallel case-control studies from the SCOPE cohort
por: Souza, Renato T., et al.
Publicado: (2019)